Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-11.21	68.02	76.61
Graham Fair Price	-26.65	4107.01	5599.17
PEG	659.34	10.77	1.42
Price/Book	15.15	1.54	1.33
Price/Cash Flow	-230.02	-161.52	-48.94
Prices/Earnings	-116.38	-500.88	-231.48
Price/Sales	9.95	9.17	8.34
Price/FCF	-230.02	-161.52	-48.94
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	31.42	0.09	0.07
Operating Margin	276.90	0.02	< 0.005
ROA	49.11	< 0.005	< 0.005
ROE	< 0.005	< 0.005	46.78
ROIC	< 0.005	< 0.005	-96.85
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.04	-30.12
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.64	2.97	363.24
EPS QOQ	-1.63	0.46	-71.50
FCF QOQ	0.43	0.65	49.37
Revenue QOQ	0.05	0.05	-2.73
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	145.11	141.23	-2.67
Days Sales Outstanding (DSO)	86.78	92.36	6.43
Inventory Turnover	0.62	0.64	2.74
Debt/Capitalization	0.13	0.13	2.88
Quick Ratio	2.70	2.76	2.37
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	31088.04	31258.68	0.55
Cash	14673.64	16255.34	10.78
Capex	-509.95	-781.39	-53.23
Free Cash Flow	-847.96	-297.49	64.92
Revenue	4977.94	5241.88	5.30
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.79	3.80	0.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-15.63	-20.30	-29.91
Naive Interpretation	Member

06 - Financial Health · Bad

Rating